Creative Medical Technology (CELZ) Competitors $3.12 -0.01 (-0.16%) As of 03:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. MRSN, TPST, KZR, MAAQ, OKUR, GBIO, MIRA, MURA, MDCX, and RNTXShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Mersana Therapeutics (MRSN), Tempest Therapeutics (TPST), Kezar Life Sciences (KZR), Mana Capital Acquisition (MAAQ), OnKure Therapeutics (OKUR), Generation Bio (GBIO), MIRA Pharmaceuticals (MIRA), Mural Oncology (MURA), Medicus Pharma (MDCX), and Rein Therapeutics (RNTX). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Its Competitors Mersana Therapeutics Tempest Therapeutics Kezar Life Sciences Mana Capital Acquisition OnKure Therapeutics Generation Bio MIRA Pharmaceuticals Mural Oncology Medicus Pharma Rein Therapeutics Creative Medical Technology (NASDAQ:CELZ) and Mersana Therapeutics (NASDAQ:MRSN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment. Is CELZ or MRSN more profitable? Creative Medical Technology has a net margin of 0.00% compared to Mersana Therapeutics' net margin of -212.94%. Creative Medical Technology's return on equity of -82.99% beat Mersana Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Creative Medical TechnologyN/A -82.99% -79.49% Mersana Therapeutics -212.94%-990.16%-54.85% Which has more volatility & risk, CELZ or MRSN? Creative Medical Technology has a beta of 2.04, indicating that its share price is 104% more volatile than the S&P 500. Comparatively, Mersana Therapeutics has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Which has higher valuation & earnings, CELZ or MRSN? Creative Medical Technology has higher earnings, but lower revenue than Mersana Therapeutics. Creative Medical Technology is trading at a lower price-to-earnings ratio than Mersana Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreative Medical Technology$10K803.67-$5.49M-$3.18-0.98Mersana Therapeutics$40.50M0.91-$69.19M-$14.62-0.50 Do analysts prefer CELZ or MRSN? Mersana Therapeutics has a consensus price target of $56.60, suggesting a potential upside of 669.02%. Given Mersana Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Mersana Therapeutics is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Creative Medical Technology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Mersana Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in CELZ or MRSN? 1.4% of Creative Medical Technology shares are held by institutional investors. Comparatively, 93.9% of Mersana Therapeutics shares are held by institutional investors. 1.8% of Creative Medical Technology shares are held by insiders. Comparatively, 13.0% of Mersana Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media favor CELZ or MRSN? In the previous week, Mersana Therapeutics had 22 more articles in the media than Creative Medical Technology. MarketBeat recorded 27 mentions for Mersana Therapeutics and 5 mentions for Creative Medical Technology. Creative Medical Technology's average media sentiment score of 0.86 beat Mersana Therapeutics' score of 0.01 indicating that Creative Medical Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Creative Medical Technology 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mersana Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 14 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMersana Therapeutics beats Creative Medical Technology on 9 of the 16 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.02M$3.13B$5.71B$9.79BDividend YieldN/A2.21%3.77%4.10%P/E Ratio-0.9820.9230.9125.28Price / Sales803.67232.70404.2188.50Price / CashN/A41.5625.2228.45Price / Book0.869.779.536.01Net Income-$5.49M-$54.74M$3.26B$265.34M7 Day Performance6.68%8.37%4.66%2.89%1 Month Performance12.45%7.94%5.35%1.61%1 Year Performance-11.00%18.27%32.14%25.61% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology1.9766 of 5 stars$3.12-0.2%N/A-10.9%$8.02M$10K-0.985Short Interest ↓MRSNMersana Therapeutics4.1684 of 5 stars$6.07+1.7%$130.00+2,041.7%-78.1%$29.76M$34.01M-0.41150Earnings ReportAnalyst RevisionTPSTTempest Therapeutics2.2415 of 5 stars$8.81+10.0%$30.00+240.5%-43.8%$29.50MN/A-0.6020Positive NewsEarnings ReportKZRKezar Life Sciences3.6741 of 5 stars$3.90-0.8%$39.50+912.8%-35.3%$28.71M$7M-0.3660Earnings ReportShort Interest ↑Analyst RevisionMAAQMana Capital AcquisitionN/A$3.45-10.9%N/A+758.2%$28.03MN/A0.001High Trading VolumeOKUROnKure Therapeutics3.4916 of 5 stars$2.00-1.5%$32.33+1,516.7%N/A$27.43MN/A-0.38N/AEarnings ReportAnalyst RevisionGBIOGeneration Bio3.269 of 5 stars$4.05+0.2%$80.00+1,875.3%-74.8%$27.21M$19.89M-0.38150Earnings ReportAnalyst ForecastAnalyst RevisionGap UpHigh Trading VolumeMIRAMIRA Pharmaceuticals3.2581 of 5 stars$1.47+3.5%$17.00+1,056.5%-22.3%$27.08MN/A-2.882Earnings ReportShort Interest ↓MURAMural Oncology3.0268 of 5 stars$1.66+7.1%$12.00+622.9%-46.3%$26.85MN/A-0.19119High Trading VolumeMDCXMedicus Pharma1.9301 of 5 stars$2.24+13.7%$23.50+949.1%N/A$26.74MN/A-1.67N/AEarnings ReportAnalyst RevisionGap UpRNTXRein TherapeuticsN/A$1.18+1.7%N/AN/A$26.73MN/A-0.419Earnings Report Related Companies and Tools Related Companies Mersana Therapeutics Alternatives Tempest Therapeutics Alternatives Kezar Life Sciences Alternatives Mana Capital Acquisition Alternatives OnKure Therapeutics Alternatives Generation Bio Alternatives MIRA Pharmaceuticals Alternatives Mural Oncology Alternatives Medicus Pharma Alternatives Rein Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 8/18/2025 by MarketBeat.com Staff From Our Partners"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.